News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BD Diagnostic Systems and Bruker Corporation Collaborate to Improve Microbial Identification and Antimicrobial Susceptibility Testing


9/29/2010 9:59:09 AM

FRANKLIN LAKES, N.J. & BILLERICA, Mass.--(BUSINESS WIRE)--BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), and Bruker Daltonics Inc., a subsidiary of Bruker Corporation (NASDAQ: BRKR), announced today an international co-development and co-marketing collaboration that will promote an emerging, integrated approach to bacterial and fungal identification and antimicrobial susceptibility testing. This new approach has the potential to transform how traditional microbiology has been performed for decades.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES